1. United States of America Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals, Inc.

ADRX
ADARx Pharmaceuticals, Inc.US flagNASDAQ
18.25
USD
-1.29
- -
1.87BMarket Cap

Income Statement (USD)

Income Statement APIChatGPT
2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
3
+ Sales & Services Revenue
- -
3
- Cost of Revenue
- -
- -
+ Cost of Goods & Services
- -
- -
Gross Profit
- -
- -
+ Other Operating Income
- -
-3
- Operating Expenses
58
92
+ Selling, General & Admin
15
20
+ Research & Development
43
72
+ Other Operating Expense
- -
- -
Operating Income (Loss)
-58
-88
- Non-Operating (Income) Loss
-12
-15
+ Interest Expense, Net
-11
-14
+ Interest Expense
- -
- -
- Interest Income
11
14
+ Other Non-Op (Income) Loss
- -
-2
Pretax Income
-46
-73
- Income Tax Expense (Benefit)
- -
- -
- (Income) Loss from Affiliates
- -
- -
Income (Loss) from Cont Ops
-46
-73
- Net Extraordinary Losses (Gains)
- -
- -
+ Discontinued Operations
- -
- -
+ Extraord. & Accounting Changes
- -
- -
Income (Loss) Incl. MI
-46
-73
- Minority Interest
- -
- -
Net Income, GAAP
-46
-73
- Preferred Dividends
- -
- -
- Other Adjustments
- -
- -
Net Income Avail to Common, GAAP
-46
-73
EBIT
-58
-88
EBITDA
-57
-86
EBITDA Margin (%)
- -
-2,494.58
EBITA
-58
-88
Gross Margin (%)
- -
100
Operating Margin (%)
- -
-2,562.05
Profit Margin (%)
- -
-2,119.11
Sales per Employee
- -
- -
Dividend per Share
- -
- -
Depreciation Expense
2
2
Basic Weighted Avg Shares
75
75
Basic EPS, GAAP
-0.62
-0.97
Basic EPS from Cont Ops
-0.62
-0.97
Diluted Weighted Avg Shares
75
75
Diluted EPS, GAAP
-0.62
-0.97
Diluted EPS from Cont Ops
-0.62
-0.97

Balance Sheet (USD)

Balance Sheet APIChatGPT
2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
Total Current Assets
226
493
+ Cash, Cash Equivalents & STI
219
480
+ Cash & Cash Equivalents
14
67
+ ST Investments
205
413
+ Accounts & Notes Receiv
- -
- -
+ Accounts Receivable, Net
- -
- -
+ Notes Receivable, Net
- -
- -
+ Loans Receivable, Net
- -
- -
+ Other Receivable, Net
- -
- -
+ Inventories
- -
- -
+ Raw Materials
- -
- -
+ Work In Process
- -
- -
+ Finished Goods
- -
- -
+ Inventory Adjustments
- -
- -
+ Other Inventory
- -
- -
+ Other ST Assets
6
13
+ Misc ST Assets
- -
- -
+ Prepaid Expenses
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
+ ST Assets Held-for-Sale
- -
- -
+ ST Deferred Tax Assets
- -
- -
Total Noncurrent Assets
8
14
+ Property, Plant & Equip, Net
7
12
+ Property, Plant & Equip
10
16
- Accumulated Depreciation
3
4
+ LT Investments & Receivables
- -
- -
+ LT Investments
- -
- -
+ LT Receivables
- -
- -
+ Other LT Assets
1
2
+ Total Intangible Assets
- -
- -
+ Goodwill
- -
- -
+ Other Intangible Assets
- -
- -
+ LT Deferred Tax Assets
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
+ Misc LT Assets
1
2
Total Assets
233
508
+ Payables & Accruals
5
9
+ Accounts Payable
1
6
+ Accrued Taxes
- -
- -
+ Interest & Dividends Payable
- -
- -
+ Other Payables & Accruals
3
3
+ ST Debt
1
2
+ ST Borrowings
- -
- -
+ ST Finance Leases
1
2
+ Other ST Liabilities
3
19
+ Deferred Revenue
- -
17
+ Derivatives & Hedging
- -
- -
+ Deferred Tax Liabilities
- -
- -
+ Misc ST Liabilities
3
3
Total Current Liabilities
9
30
+ LT Debt
4
6
+ LT Borrowings
- -
- -
+ LT Finance Leases
4
6
+ Other LT Liabilities
358
673
+ Accrued Liabilities
- -
315
+ Pension Liabilities
- -
- -
+ Deferred Revenue
- -
- -
+ Deferred Tax Liabilities
- -
- -
+ Derivatives & Hedging
- -
- -
+ Misc LT Liabilities
358
358
Total Noncurrent Liabilities
362
679
Total Liabilities
371
710
+ Preferred Equity and Hybrid Capital
- -
- -
+ Share Capital & APIC
10
16
+ Common Stock
- -
- -
+ Additional Paid in Capital
10
16
- Treasury Stock
- -
- -
+ Retained Earnings
-148
-221
+ Other Equity
- -
2
Equity Before Minority Interest
-137
-202
+ Minority/Non Controlling Interest
- -
- -
Total Equity
-137
-202
Total Liabilities & Equity
233
508
Shares Outstanding
102
102
Number of Employees
- -
- -
Capital Leases - Total
4
8
Net Debt
-14
-67
Net Debt to Equity
10.23
32.89
Tangible Common Equity Ratio
-58.75
-39.84
Current Ratio
25.25
16.18
Cash Conversion Cycle
- -
- -

Cash Flow Statement (USD)

Cash Flow Statement APIChatGPT
2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
+ Net Income
-46
-73
+ Depreciation & Amortization
2
2
+ Non-Cash Items
-3
3
+ Stock-Based Compensation
4
6
+ Deferred Income Taxes
- -
- -
+ Asset Impairment Charge
- -
- -
+ Other Non-Cash Adj
-7
-3
+ Chg in Non-Cash Work Cap
-1
330
+ (Inc) Dec in Accts Receiv
- -
- -
+ (Inc) Dec in Inventories
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
-4
+ Inc (Dec) in Accts Payable
1
4
+ Inc (Dec) in Other
-1
329
+ Net Cash From Disc Ops
- -
- -
Cash from Operating Activities
-49
262
+ Change in Fixed & Intang
- -
- -
+ Disp in Fixed & Intang
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
+ Disp of Intangible Assets
- -
- -
+ Acq of Fixed & Intang
- -
-3
+ Acq of Fixed Prod Assets
- -
-3
+ Acq of Intangible Assets
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
+ Increase in Capital Stock
- -
- -
+ Decrease in Capital Stock
- -
- -
+ Net Change in LT Investment
40
-207
+ Dec in LT Investment
221
196
+ Inc in LT Investment
-181
-403
+ Net Cash From Acq & Div
- -
- -
+ Cash from Divestitures
- -
- -
+ Cash for Acq of Subs
- -
- -
+ Cash for JVs
- -
- -
+ Other Investing Activities
- -
- -
+ Net Cash From Disc Ops
- -
- -
Cash from Investing Activities
40
-210
+ Dividends Paid
- -
- -
+ Net Cash From Debt
- -
- -
+ Cash From Debt
- -
- -
+ Repayments of Debt
- -
- -
+ Other Financing Activities
- -
- -
+ Net Cash From Disc Ops
- -
- -
Cash from Financing Activities
- -
- -
Effect of Foreign Exchange Rates
- -
- -
Net Changes in Cash
-9
52
EBITDA
-57
-86
EBITDA Margin (%)
- -
-2,494.58
Free Cash Flow
-49
259
Net Cash Paid for Acquisitions
- -
- -
Free Cash Flow to Firm
- -
- -
Free Cash Flow to Equity
- -
259
Free Cash Flow per Basic Share
-0.65
3.44
Price/Free Cash Flow
- -
- -
Cash Flow to Net Income
1.05
-3.59
Capital Expenditures
- -
-3